Biotech Company With Clinical Operations Developing Psychedelic Medicine To Treat Addiction
First 3 UK Clinics Opened In 2021, Targeting 20 Clinics By 2024 ~$100M In Revenue
fast facts
- name Awakn Life Sciences Corp.
- symbol AWKN
- exchange NEO Exchange
- financials View Filings
- shares outstanding
- industry Psychedelics
- transfer agent Endeavor Trust Corporation
- website https://awaknlifesciences...
recent updates
-
-
-
Press Release -
Awakn Life Sciences Reports Strong Q2 2022 Results -
-
most recent messages
top rated messages